TERADIA DIAMOND INTENSIVE HYDROGEL EYE

Manufacturer
NanoDia Lab Co Ltd
Effective date
2018-09-27
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 22:58:07

Label at a glance#

ProductTERADIA DIAMOND INTENSIVE HYDROGEL EYE
Active ingredientADENOSINE, NIACINAMIDE
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Niacinamide, Adenosine

INACTIVE INGREDIENT SECTION

Glycerin, etc

OTC - PURPOSE SECTION

Anti-Wrinkle, Whitening

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out of reach of the children

INDICATIONS & USAGE SECTION

  1. After cleansing your face, apply toner with a cotton pad and sweep gently over face.
  2. Pick out a piece of eye patch on container.
  3. Attach the patch on the site you want like your around eyes, dark circle area and etc.
  4. Leave on for 10-15 minutes and remove the patch.
  5. Absorb the excess liquid by patting your around eyes

WARNINGS SECTION

1. Do not use in the following cases(Eczema and scalp wounds)
2.Side Effects
1)Due to the use of this druf if rash, irritation, itching and symptopms of hypersnesitivity occur dicontinue use and consult your phamacisr or doctor
3.General Precautions
1)If in contact with the eyes, wash out thoroughty with water If the symptoms are servere, seek medical advice immediately
2)This product is for exeternal use only. Do not use for internal use
4.Storage and handling precautions
1)If possible, avoid direct sunlight and store in cool and area of low humidity
2)In order to maintain the quality of the product and avoid misuse
3)Avoid placing the product near fire and store out in reach of children

DOSAGE & ADMINISTRATION SECTION

for external use only


PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ADENOSINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d676a241-be05-4740-b3ee-1a5f2ed422d2Product name420180615
dd8bd48f-20d6-43c7-b471-3ae872868afaProduct name320180125
d41954ff-bc63-4b2c-aba0-9146707659d7Product name220151117

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
71483-0002-12020-01-31C16284748780-19d75b9d1-137a-f424-e053-dadaa90a57ceDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71483-0002-1TERADIA DIAMOND INTENSIVE HYDROGEL EYE90 g in 1 JARPATCH902

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71483-0002TERADIA DIAMOND INTENSIVE HYDROGEL EYE (NIACINAMIDE, ADENOSINE) PATCH [NANODIA LAB CO LTD]2Legacy NDC, 1 package rows20190109_60d3f3b0-b1de-629a-e053-2991aa0aec24.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71483-000271483-0002-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
ADENOSINEK72T3FS567ACTIB
NIACINAMIDE25X51I8RD4ACTIB
GLYCERINPDC6A3C0OXIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
76e5bc9d-7e58-0636-e053-2a91aa0a31c360d3f3b0-b1de-629a-e053-2991aa0aec242018-09-27WarningsExact identifier
spl id: 76e5bc9d-7e58-0636-e053-2a91aa0a31c3
spl set id: 60d3f3b0-b1de-629a-e053-2991aa0aec24

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.